Melanie Solomon | IR |
Ming Hsieh | CEO |
Paul Kim | CFO |
Brandon Perthuis | Chief Commercial Officer |
Dr. Ray Yin | President and Chief Scientific Officer, Fulgent Pharma |
Dan Leonard | Credit Suisse |
Hello and welcome to the Fulgent Genetics Q3 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. It's now my please to turn the call over to your host, Melanie Solomon, Investor Relations. Please go ahead.